Condition: Nasopharyngeal Carcinoma · Sponsor: Sun Yat-sen University
This is an Open Label, Non-Inferiority, Multicenter, Randomized Phase 3 Trial aimed to investigate the impact of reduced-dose radiotherapy in combination with chemotherapy and immunotherapy on patients' prognosis and complication compared with conventional-dose radiotherapy in combination with chemotherapy and immunotherapy for treatment-sensitive stage III NPC patients screened out according to the treatment response.
This description comes directly from the study's public registry record.
Jun Ma · +862087343469 · majun2@mail.sysu.edu.cn
Kai-Bin Yang · +8613725368062 · yangkb@sysucc.org.cn
Always discuss trial participation with your own doctor first.
| Fujian Cancer Hospital | Fuzhou, Fujian, China | Recruiting |
| The First Affiliated Hospital of Xiamen University | Xiamen, Fujian, China | Recruiting |
| Dongguan People's Hospital | Dongguan, Guangdong, China | Recruiting |
| The First People's Hospital of Foshan | Foshan, Guangdong, China | Recruiting |
| Sun Yat-Sen University Cancer Center | Guangzhou, Guangdong, China | Recruiting |
| The Affiliated Panyu Central Hospital of Guangzhou Medical University | Guangzhou, Guangdong, China | Recruiting |
| Cancer Hospital of Shantou University Medical College | Shantou, Guangdong, China | Recruiting |
| Affiliated Hospital of Guangdong Medical University | Zhanjiang, Guangdong, China | Recruiting |
| Guangdong Nongken Central Hospital | Zhanjiang, Guangdong, China | Recruiting |
| Cancer Hospital of Guangxi Medical University | Nanning, Guangxi, China | Recruiting |
| Cancer Hospital of Guizhou Medical University | Guiyang, Guizhou, China | Recruiting |
| The Second Affiliated Hospital of Hainan Medical University | Haikou, Hainan, China | Recruiting |
+ 14 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06239727